Cellular fatty acid metabolism and cancer

Cell Metabolism

Volumn 18, Issue 2, 2013, Pages 153-161

  Currie, Erin ^a   Schulze, Almut ^c   Zechner, Rudolf ^d   Walther, Tobias C ^e   Farese, Robert V ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d UNIVERSITY OF GRAZ   (Austria)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; 6,7 DIHYDRO 4 HYDROXY 3 (2' HYDROXY 1,1' BIPHENYL 4 YL) 6 OXOTHIENO[2,3 B]PYRIDINE 5 CARBONITRILE; ACYLGLYCEROL LIPASE; BENZENE; CERULENIN; DIACYLGLYCEROL ACYLTRANSFERASE; EPIGALLOCATECHIN GALLATE; ETOMOXIR; FATTY ACID; FATTY ACID SYNTHASE; FLAVONOID; HORMONE SENSITIVE LIPASE; MALONYL COENZYME A DECARBOXYLASE; METFORMIN; RANOLAZINE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE;

CANCER CELL; CANCER CONTROL; CELL METABOLISM; CELL PROLIFERATION; ENERGY METABOLISM; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; HUMAN; LIPID METABOLISM; LIPID STORAGE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

CELL PROLIFERATION; ENERGY METABOLISM; FATTY ACIDS; HUMANS; LIPID METABOLISM; NEOPLASMS;

EID: 84881372774     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.05.017     Document Type: Review

References (80)

1. A.K. Agarwal Lysophospholipid acyltransferases: 1-acylglycerol-3- phosphate O-acyltransferases. From discovery to disease Curr. Opin. Lipidol. 23 2012 290 302
2. H. Ariyama, N. Kono, S. Matsuda, T. Inoue, and H. Arai Decrease in membrane phospholipid unsaturation induces unfolded protein response J. Biol. Chem. 285 2010 22027 22035
3. C. Bagnato, and R.A. Igal Overexpression of diacylglycerol acyltransferase-1 reduces phospholipid synthesis, proliferation, and invasiveness in simian virus 40-transformed human lung fibroblasts J. Biol. Chem. 278 2003 52203 52211
4. D.E. Bauer, G. Hatzivassiliou, F. Zhao, C. Andreadis, and C.B. Thompson ATP citrate lyase is an important component of cell growth and transformation Oncogene 24 2005 6314 6322
5. A. Beckers, S. Organe, L. Timmermans, K. Scheys, A. Peeters, K. Brusselmans, G. Verhoeven, and J.V. Swinnen Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells Cancer Res. 67 2007 8180 8187
6. P.T. Bozza, and J.P. Viola Lipid droplets in inflammation and cancer Prostaglandins Leukot. Essent. Fatty Acids 82 2010 243 250
7. K. Brusselmans, E. De Schrijver, G. Verhoeven, and J.V. Swinnen RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells Cancer Res. 65 2005 6719 6725
8. Y. Cao, A.T. Pearman, G.A. Zimmerman, T.M. McIntyre, and S.M. Prescott Intracellular unesterified arachidonic acid signals apoptosis Proc. Natl. Acad. Sci. USA 97 2000 11280 11285
9. O. Catalina-Rodriguez, V.K. Kolukula, Y. Tomita, A. Preet, F. Palmieri, A. Wellstein, S. Byers, A.J. Giaccia, E. Glasgow, C. Albanese, and M.L. Avantaggiati The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis Oncotarget 3 2012 1220 1235
10. V. Chajès, M. Cambot, K. Moreau, G.M. Lenoir, and V. Joulin Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival Cancer Res. 66 2006 5287 5294
11. S.K. Das, S. Eder, S. Schauer, C. Diwoky, H. Temmel, B. Guertl, G. Gorkiewicz, K.P. Tamilarasan, P. Kumari, and M. Trauner Adipose triglyceride lipase contributes to cancer-associated cachexia Science 333 2011 233 238
12. E. De Schrijver, K. Brusselmans, W. Heyns, G. Verhoeven, and J.V. Swinnen RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells Cancer Res. 63 2003 3799 3804
13. R.J. DeBerardinis, and C.B. Thompson Cellular metabolism and disease: what do metabolic outliers teach us? Cell 148 2012 1132 1144
14. R.J. DeBerardinis, A. Mancuso, E. Daikhin, I. Nissim, M. Yudkoff, S. Wehrli, and C.B. Thompson Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis Proc. Natl. Acad. Sci. USA 104 2007 19345 19350
15. R.A. DeFilippis, H. Chang, N. Dumont, J.T. Rabban, Y.Y. Chen, G.V. Fontenay, H.K. Berman, M.L. Gauthier, J. Zhao, and D. Hu CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues Cancer Discov 2 2012 826 839
16. S.L. Ettinger, R. Sobel, T.G. Whitmore, M. Akbari, D.R. Bradley, M.E. Gleave, and C.C. Nelson Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence Cancer Res. 64 2004 2212 2221
17. R.V. Farese Jr., and T.C. Walther Lipid droplets finally get a little R-E-S-P-E-C-T Cell 139 2009 855 860
18. V. Fritz, Z. Benfodda, G. Rodier, C. Henriquet, F. Iborra, C. Avancès, Y. Allory, A. de la Taille, S. Culine, and H. Blancou Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice Mol. Cancer Ther. 9 2010 1740 1754
19. K. Glunde, Z.M. Bhujwalla, and S.M. Ronen Choline metabolism in malignant transformation Nat. Rev. Cancer 11 2011 835 848
20. O. Göransson, A. McBride, S.A. Hawley, F.A. Ross, N. Shpiro, M. Foretz, B. Viollet, D.G. Hardie, and K. Sakamoto Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase J. Biol. Chem. 282 2007 32549 32560
21. B. Griffiths, C.A. Lewis, K. Bensaad, S. Ros, Q. Zhang, E.C. Ferber, S. Konisti, B. Peck, H. Miess, P. East, M. Wakelam, A.L. Harris, and A. Schulze Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth Cancer & Metabolism 1 2013 10.1186/2049-3002-1-3 Published online January 23, 2013
22. D. Guo, I.J. Hildebrandt, R.M. Prins, H. Soto, M.M. Mazzotta, J. Dang, J. Czernin, J.Y. Shyy, A.D. Watson, and M. Phelps The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis Proc. Natl. Acad. Sci. USA 106 2009 12932 12937
23. D. Guo, R.M. Prins, J. Dang, D. Kuga, A. Iwanami, H. Soto, K.Y. Lin, T.T. Huang, D. Akhavan, and M.B. Hock EGFR signaling through an Akt-SREBP-1- dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy Sci. Signal. 2 2009 ra82
24. I. Hapala, E. Marza, and T. Ferreira Is fat so bad? Modulation of endoplasmic reticulum stress by lipid droplet formation Biol. Cell 103 2011 271 285
25. G. Hatzivassiliou, F. Zhao, D.E. Bauer, C. Andreadis, A.N. Shaw, D. Dhanak, S.R. Hingorani, D.A. Tuveson, and C.B. Thompson ATP citrate lyase inhibition can suppress tumor cell growth Cancer Cell 8 2005 311 321
26. J.D. Horton, J.L. Goldstein, and M.S. Brown SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver J. Clin. Invest. 109 2002 1125 1131
27. P.P. Hsu, and D.M. Sabatini Cancer cell metabolism: Warburg and beyond Cell 134 2008 703 707
28. R.A. Igal Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer Carcinogenesis 31 2010 1509 1515
29. K. Ishimoto, H. Nakamura, K. Tachibana, D. Yamasaki, A. Ota, K. Hirano, T. Tanaka, T. Hamakubo, J. Sakai, T. Kodama, and T. Doi Sterol-mediated regulation of human lipin 1 gene expression in hepatoblastoma cells J. Biol. Chem. 284 2009 22195 22205
30. S.M. Jeon, N.S. Chandel, and N. Hay AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress Nature 485 2012 661 665
31. C. Jose, E. Hébert-Chatelain, N. Bellance, A. Larendra, M. Su, K. Nouette-Gaulain, and R. Rossignol AICAR inhibits cancer cell growth and triggers cell-type distinct effects on OXPHOS biogenesis, oxidative stress and Akt activation Biochim. Biophys. Acta 1807 2011 707 718
32. S. Kamisuki, T. Shirakawa, A. Kugimiya, L. Abu-Elheiga, H.Y. Choo, K. Yamada, H. Shimogawa, S.J. Wakil, and M. Uesugi Synthesis and evaluation of diarylthiazole derivatives that inhibit activation of sterol regulatory element-binding proteins J. Med. Chem. 54 2011 4923 4927
33. J.H. Kim, T.M. Lewin, and R.A. Coleman Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones J. Biol. Chem. 276 2001 24667 24673
34. M. Knobloch, S.M. Braun, L. Zurkirchen, C. von Schoultz, N. Zamboni, M.J. Araúzo-Bravo, W.J. Kovacs, O. Karalay, U. Suter, and R.A. Machado Metabolic control of adult neural stem cell activity by Fasn-dependent lipogenesis Nature 493 2013 226 230
35. C. Kumar-Sinha, K.W. Ignatoski, M.E. Lippman, S.P. Ethier, and A.M. Chinnaiyan Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis Cancer Res. 63 2003 132 139
36. M. Laplante, and D.M. Sabatini An emerging role of mTOR in lipid biosynthesis Curr. Biol. 19 2009 R1046 R1052
37. C.A. Lewis, B. Griffiths, C.R. Santos, M. Pende, and A. Schulze Regulation of the SREBP transcription factors by mTORC1 Biochem. Soc. Trans. 39 2011 495 499
38. G. Liang, J. Yang, J.D. Horton, R.E. Hammer, J.L. Goldstein, and M.S. Brown Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c J. Biol. Chem. 277 2002 9520 9528
39. T.M. Loftus, D.E. Jaworsky, G.L. Frehywot, C.A. Townsend, G.V. Ronnett, M.D. Lane, and F.P. Kuhajda Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors Science 288 2000 2379 2381
40. R. Lupu, and J.A. Menendez Pharmacological inhibitors of Fatty Acid Synthase (FASN) - catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? Curr. Pharm. Biotechnol. 7 2006 483 493
41. D.G. Mashek, L.O. Li, and R.A. Coleman Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet J. Lipid Res. 47 2006 2004 2010
42. T. Mashima, T. Oh-hara, S. Sato, M. Mochizuki, Y. Sugimoto, K. Yamazaki, J. Hamada, M. Tada, T. Moriuchi, and Y. Ishikawa p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target J. Natl. Cancer Inst. 97 2005 765 777
43. G. Medes, A. Thomas, and S. Weinhouse Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro Cancer Res. 13 1953 27 29
44. J.A. Menendez, and R. Lupu Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat. Rev. Cancer 7 2007 763 777
45. C.M. Metallo, P.A. Gameiro, E.L. Bell, K.R. Mattaini, J. Yang, K. Hiller, C.M. Jewell, Z.R. Johnson, D.J. Irvine, and L. Guarente Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia Nature 481 2012 380 384
46. L. Michalik, B. Desvergne, and W. Wahli Peroxisome-proliferator-activated receptors and cancers: complex stories Nat. Rev. Cancer 4 2004 61 70
47. T. Migita, T. Narita, K. Nomura, E. Miyagi, F. Inazuka, M. Matsuura, M. Ushijima, T. Mashima, H. Seimiya, and Y. Satoh ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer Cancer Res. 68 2008 8547 8554
48. A.R. Mullen, W.W. Wheaton, E.S. Jin, P.H. Chen, L.B. Sullivan, T. Cheng, Y. Yang, W.M. Linehan, N.S. Chandel, and R.J. DeBerardinis Reductive carboxylation supports growth in tumour cells with defective mitochondria Nature 481 2012 385 388
49. K.M. Nieman, H.A. Kenny, C.V. Penicka, A. Ladanyi, R. Buell-Gutbrod, M.R. Zillhardt, I.L. Romero, M.S. Carey, G.B. Mills, and G.S. Hotamisligil Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth Nat. Med. 17 2011 1498 1503
50. D.K. Nomura, J.Z. Long, S. Niessen, H.S. Hoover, S.W. Ng, and B.F. Cravatt Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis Cell 140 2010 49 61
51. B. Ogretmen, and Y.A. Hannun Biologically active sphingolipids in cancer pathogenesis and treatment Nat. Rev. Cancer 4 2004 604 616
52. M. Ookhtens, R. Kannan, I. Lyon, and N. Baker Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor Am. J. Physiol. 247 1984 R146 R153
53. C.M. Paton, and J.M. Ntambi Biochemical and physiological function of stearoyl-CoA desaturase Am. J. Physiol. Endocrinol. Metab. 297 2009 E28 E37
54. T.R. Peterson, S.S. Sengupta, T.E. Harris, A.E. Carmack, S.A. Kang, E. Balderas, D.A. Guertin, K.L. Madden, A.E. Carpenter, B.N. Finck, and D.M. Sabatini mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway Cell 146 2011 408 420
55. L.S. Pike, A.L. Smift, N.J. Croteau, D.A. Ferrick, and M. Wu Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells Biochim. Biophys. Acta 1807 2011 726 734
56. E.S. Pizer, J. Thupari, W.F. Han, M.L. Pinn, F.J. Chrest, G.L. Frehywot, C.A. Townsend, and F.P. Kuhajda Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts Cancer Res. 60 2000 213 218
57. M.N. Pollak Investigating metformin for cancer prevention and treatment: the end of the beginning Cancer Discov 2 2012 778 790
58. M.D. Resh Targeting protein lipidation in disease Trends Mol. Med. 18 2012 206 214
59. U.V. Roongta, J.G. Pabalan, X. Wang, R.P. Ryseck, J. Fargnoli, B.J. Henley, W.P. Yang, J. Zhu, M.T. Madireddi, and R.M. Lawrence Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy Mol. Cancer Res. 9 2011 1551 1561
60. S. Ros, C.R. Santos, S. Moco, F. Baenke, G. Kelly, M. Howell, N. Zamboni, and A. Schulze Functional metabolic screen identifies 6-phosphofructo-2-kinase/ fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival Cancer Discov 2 2012 328 343
61. I. Samudio, R. Harmancey, M. Fiegl, H. Kantarjian, M. Konopleva, B. Korchin, K. Kaluarachchi, W. Bornmann, S. Duvvuri, H. Taegtmeyer, and M. Andreeff Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction J. Clin. Invest. 120 2010 142 156
62. C.R. Santos, and A. Schulze Lipid metabolism in cancer FEBS J. 279 2012 2610 2623
63. A. Schulze, and A.L. Harris How cancer metabolism is tuned for proliferation and vulnerable to disruption Nature 491 2012 364 373
64. W. Shao, and P.J. Espenshade Expanding roles for SREBP in metabolism Cell Metab. 16 2012 414 419
65. J.V. Swinnen, A. Beckers, K. Brusselmans, S. Organe, J. Segers, L. Timmermans, F. Vanderhoydonc, L. Deboel, R. Derua, and E. Waelkens Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype Cancer Res. 65 2005 2441 2448
66. J.V. Swinnen, K. Brusselmans, and G. Verhoeven Increased lipogenesis in cancer cells: new players, novel targets Curr. Opin. Clin. Nutr. Metab. Care 9 2006 358 365
67. K. Takeuchi, and K. Reue Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis Am. J. Physiol. Endocrinol. Metab. 296 2009 E1195 E1209
68. C.G. Van Horn, J.M. Caviglia, L.O. Li, S. Wang, D.A. Granger, and R.A. Coleman Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6 Biochemistry 44 2005 1635 1642
69. E. Viennois, K. Mouzat, J. Dufour, L. Morel, J.M. Lobaccaro, and S. Baron Selective liver X receptor modulators (SLiMs): what use in human health? Mol. Cell. Endocrinol. 351 2012 129 141
70. S.J. Wakil, and L.A. Abu-Elheiga Fatty acid metabolism: target for metabolic syndrome J. Lipid Res. 50 Suppl 2009 S138 S143
71. O. Warburg On the origin of cancer cells Science 123 1956 309 314
72. K.E. Wellen, G. Hatzivassiliou, U.M. Sachdeva, T.V. Bui, J.R. Cross, and C.B. Thompson ATP-citrate lyase links cellular metabolism to histone acetylation Science 324 2009 1076 1080
73. J.R. Weng, C.Y. Chen, J.J. Pinzone, M.D. Ringel, and C.S. Chen Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones Endocr. Relat. Cancer 13 2006 401 413
74. K.J. Williams, J.P. Argus, Y. Zhu, M.Q. Wilks, B.N. Marbois, A.G. York, Y. Kidani, A.L. Pourzia, D. Akhavan, and D.N. Lisiero An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity Cancer Res. 73 2013 2850 2862
75. D.R. Wise, R.J. DeBerardinis, A. Mancuso, N. Sayed, X.Y. Zhang, H.K. Pfeiffer, I. Nissim, E. Daikhin, M. Yudkoff, S.B. McMahon, and C.B. Thompson Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction Proc. Natl. Acad. Sci. USA 105 2008 18782 18787
76. M.P. Wymann, and R. Schneiter Lipid signalling in disease Nat. Rev. Mol. Cell Biol. 9 2008 162 176
77. Y. Yamashita, T. Kumabe, Y.Y. Cho, M. Watanabe, J. Kawagishi, T. Yoshimoto, T. Fujino, M.J. Kang, and T.T. Yamamoto Fatty acid induced glioma cell growth is mediated by the acyl-CoA synthetase 5 gene located on chromosome 10q25.1-q25.2, a region frequently deleted in malignant gliomas Oncogene 19 2000 5919 5925
78. Y. Yokoyama, and H. Mizunuma Peroxisome proliferator-activated receptor and epithelial ovarian cancer Eur. J. Gynaecol. Oncol. 31 2010 612 615
79. K. Zaugg, Y. Yao, P.T. Reilly, K. Kannan, R. Kiarash, J. Mason, P. Huang, S.K. Sawyer, B. Fuerth, and B. Faubert Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress Genes Dev. 25 2011 1041 1051
80. W. Zhou, Y. Tu, P.J. Simpson, and F.P. Kuhajda Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells Oncogene 28 2009 2979 2987